Hepatitis B Incidence in Individuals with Chronic Kidney Disorder: A Meta-Analysis
DOI:
https://doi.org/10.56294/hl2025619Keywords:
Hepatitis B Virus (HBV)., Chronic Kidney Disorder (CKD), End-Stage Renal Disease (ESRD), quality of life (QOL)Abstract
The hepatitis B virus is a major contributor to liver disease and has many non-liver symptoms. In addition to the significant impairment and mortality that HBV causes in the population, the most recent study indicates the role that HBV plays in the initiation and development of Chronic Kidney Disease (CKD). The causal relationship between HBV and CKD has yet to be fully elucidated. Antiviral nucleos (t) medicine compounds for HBV are already available, and they are very effective for individuals with chronic kidney disease. An increased probability of CKD has been identified in those with HBV, according to a recent meta-analysis of clinical data. Based on the most recent review, we identified six separate clinical trials. There was too much variation to draw any firm conclusions. Several proposed reasons account for the increased risk of CKD in HBsAg optimistic patients. Additional data links treatment with nucleos(t)ide equivalents to a decreased risk of end-stage renal disease (ESRD) and links undiagnosed HBV to an increased risk of ESRD in the CKD population. They advise that kidney activity and urine alterations be measured at the outset and periodically in HBV participants.
References
1. Amjad A, Kumar J, Chaudary N, Kumar K, Nazar CM, Khan K, Karmani Sr JK. Hepatitis B Vaccination status in chronic kidney disease: Experience at Pakistan institute of medical sciences. Cureus. 2019 Jul 30;11(7). DOI: 10.7759/cureus.5282
2. Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. The lancet. 2021 Aug 28;398(10302):786-802. https://doi.org/10.1016/S0140-6736(21)00519-5
3. Zhou K, Contag C, Whitaker E, Terrault N. Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses. The lancet Gastroenterology & hepatology. 2019 Mar 1;4(3):227-38. https://doi.org/10.1016/S2468-1253(18)30308-X
4. Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, Bulterys M, Chan PL, El-Sayed MH, Giaquinto C, Jonas MM. Hepatitis B virus infection in children and adolescents. The lancet Gastroenterology & hepatology. 2019 Jun 1;4(6):466-76. https://doi.org/10.1016/S2468-1253(19)30042-1
5. Agarwal P, Garg V, Karagaiah P, Szepietowski JC, Grabbe S, Goldust M. Chronic kidney disease-associated pruritus. Toxins. 2021 Jul 28;13(8):527. https://doi.org/10.3390/toxins13080527
6. Wang B, Mufti G, Agarwal K. Reactivation of hepatitis B virus infection in patients with hematologic disorders. Haematologica. 2019 Feb 7;104(3):435. doi: 10.3324/haematol.2018.210252
7. Zhao H, Zhou X, Zhou YH. Hepatitis B vaccine development and implementation. Human vaccines & immunotherapeutics. 2020 Jul 2;16(7):1533-44. https://doi.org/10.1080/21645515.2020.1732166
8. Wong GL, Wong VW, Yuen BW, Tse YK, Yip TC, Luk HW, Lui GC, Chan HL. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure. Journal of hepatology. 2020 Jan 1;72(1):57-66. https://doi.org/10.1016/j.jhep.2019.08.023
9. Hsu YC, Wong GL, Chen CH, Peng CY, Yeh ML, Cheung KS, Toyoda H, Huang CF, Trinh H, Xie Q, Enomoto M. Tenofovir versus entecavir for hepatocellular carcinoma prevention in an international consortium of chronic hepatitis B. Official journal of the American College of Gastroenterology| ACG. 2020 Feb 1;115(2):271-80. DOI: 10.14309/ajg.0000000000000428
10. Tseng CH, Hsu YC, Chen TH, Ji F, Chen IS, Tsai YN, Hai H, Hosaka T, Sezaki H, Borghi JA, Cheung R. Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2020 Dec 1;5(12):1039-52. https://doi.org/10.1016/S2468-1253(20)30249-1
11. Amponsah-Dacosta E, Tchuem CT, Anderson M. Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome. World Journal of Virology. 2020 Dec 15;9(5):54. https://doi.org/10.5501/wjv.v9.i5.54
12. Fontaine H, Alric L, Labreuche J, Legendre B, Louvet A, Antoine C, Legendre CM, Hazzan M, Kamar N, Dharancy S, Pol S. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation. Journal of Hepatology. 2019 May 1;70(5):831-8. https://doi.org/10.1016/j.jhep.2018.12.036
13. Chewcharat, A., Takkavatakarn, K., Wongrattanagorn, S., Panrong, K., Kittiskulnam, P., Eiam-Ong, S. and Susantitaphong, P., 2020. The effects of restricted protein diet supplemented with ketoanalogue on renal function, blood pressure, nutritional status, and chronic kidney disease-mineral and bone disorder in chronic kidney disease patients: a systematic review and meta-analysis. Journal of Renal Nutrition, 30(3), pp.189-199. https://doi.org/10.1053/j.jrn.2019.07.005
14. Moreno-Fernández J, García-Seco JA, Rodrigo EM, Segura AM, García-Seco F, Muñoz-Rodríguez JR. Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients. Primary Care Diabetes. 2020 Aug 1;14(4):343-8. https://doi.org/10.1016/j.pcd.2019.09.004
15. Duong MC, Nguyen VT, Otsu S, McLaws ML. Prevalence of hepatitis B and C virus infections in hemodialysis patients in Vietnam: A systematic review and meta‐analysis. JGH Open. 2020 Feb;4(1):29-38. https://doi.org/10.1002/jgh3.12199
16. Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral research. 2020 Oct 1;182:104925. https://doi.org/10.1016/j.antiviral.2020.104925
17. Kubsad D, Nilsson EE, King SE, Sadler-Riggleman I, Beck D, Skinner MK. Assessment of glyphosate induced epigenetic transgenerational inheritance of pathologies and sperm epimutations: generational toxicology. Scientific reports. 2019 Apr 23;9(1):6372. https://doi.org/10.1038/s41598-019-42860-0
18. Fabrizi F, Cerutti R, Ridruejo E. Hepatitis B virus infection as a risk factor for chronic kidney disease. Expert review of clinical pharmacology. 2019 Sep 2;12(9):867-74. https://doi.org/10.1080/17512433.2019.1657828
19. Havránková Z, Doucouliagos C, Havránek T, Stanley TD. Meta-analysis of social science research: A practitioner's guide. IES Working Paper; 2023. https://hdl.handle.net/10419/286354
20. Srikantharajah M, McAdoo S. Secondary glomerular disease. Medicine. 2023 Apr 1;51(4):252-7. https://doi.org/10.1016/j.mpmed.2023.01.003
21. Al-jelehawy AH, YASIR SJ, Al-waeli AK, Ali AR. Assessments of HBV in patients with chronic kidney illness. International Journal of Pharmaceutical Research. 2021 Jan 1;13(1):537-40. https://doi.org/10.031838/ijpr/2021.13.01.089
22. Mubarak M, Jafry N, Khan AS, Naqvi R, Elahi T. Chronic hepatitis B virus (HBV) infection presenting as crescentic membranoproliferative glomerulonephritis: A distinctly rare occurrence. Pakistan Journal of Kidney Diseases. 2021 Oct 15;5(3):82-6. https://doi.org/10.53778/pjkd53173
23. Bouteldja N, Klinkhammer BM, Bülow RD, Droste P, Otten SW, Von Stillfried SF, Moellmann J, Sheehan SM, Korstanje R, Menzel S, Bankhead P. Deep learning–based segmentation and quantification in experimental kidney histopathology. Journal of the American Society of Nephrology. 2021 Jan 1;32(1):52-68. DOI: 10.1681/ASN.2020050597
24. Alijotas-Reig J, Esteve-Valverde E, Belizna C, Selva-O'Callaghan A, Pardos-Gea J, Quintana A, Mekinian A, Anunciacion-Llunell A, Miró-Mur F. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmunity reviews. 2020 Jul 1;19(7):102569. https://doi.org/10.1016/j.autrev.2020.102569.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Amit Kumar Kumawat, Sanjiv Kumar Bansal, Lovely, Wamika Goyal, Gujjala Srinath, Nitish Vashisht (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
